Dr. Rachel Tate
Tweet
Check out my video on T2T in SpA abstracts from #ACR20 @RheumNow https://t.co/ZBvmhWyDHU
All News
Dr. John Cush
Tweet
Network Meta-Analysis of JAK and TNF Inhib in 19 AS studies (3,654pts) showed best results with TNFi (golimumab and infliximab) but JAKs also appear to be effective option. #ACR20 Abstr#1357 #UTSW @AdelaCastro222 https://t.co/HnnPD6eXW5 https://t.co/Li30kkp3P1
Dr. John Cush
Tweet
RheumNow’s expanded coverage of the annual #ACR2020 meeting is sponsored in part by @bmsnews, @HorizonNews, @SanofiGenzyme, @Novartis. All content chosen by RheumNow & its Faculty.
Dr. Rachel Tate
Tweet
axSpA patients have higher rates of c-section, pre-eclampsia, IUGR and fetal complications vs normal population. Findings from a meta-analysis/systematic review #ABS1323 #ACR20 @RheumNow https://t.co/Ya9r0td7Ev https://t.co/miNURP6bOK
Robert B Chao, MD
Tweet
Distinct gut microbiome in Ankylosing Spondylitis and AS-IBD patients compared with IBD and healthy controls.
1⃣Different alpha and beta-diversity in AS pts vs. IBD
2⃣TNFi use ➡️differentiation microbiome in IBD pts
@RheumNow #ACR20 Abs#1310 https://t.co/AGZbJZ9jtR
Dr. Rachel Tate
Tweet
Both fat mass and fat free mass have an impact on the response to bDMARDs after 6 months of treatment in AS pts. No tx response changes w/ skeletal muscle mass, visceral fat as well as water components. #ABS1376 #ACR20 @RheumNow https://t.co/oIdE8qvJPp https://t.co/wlXFf8esey
Dr. Antoni Chan
Tweet
In patients with Crohn's disease (CD), the presence of HLA-B27 and higher clinical activity of CD were associated with presence of SpA. SpA was present in 21% of early CD patients @RheumNow #ACR20 Abstr#1308
Dr. Rachel Tate
Tweet
#ABS1303 shows ASAS modification of Berlin algorithm showed optimal balance between sensitivity and specificity and represented the preferred referral strategy for patients presenting w/ undiagnosed back pain & extra-articular features. #ACR20 @RheumNow https://t.co/10VdKC3E75 https://t.co/RgC7K3V8TB
Dr Philip Robinson
Tweet
For all your nr-axSpA fanatics, there's a fantastic poster on certolizumab response in nr-axSpA stratified by MRI and CRP status #ACR20 @steverheum_hall https://t.co/WI1vdMItUO https://t.co/JnvAyyClDu
Olga Petryna
Tweet
@RheumNow #acr20 abs1306 CBP highly prevalent in anterior uveitis. 53%of uveitis pts complain of CBP. 23% eventually diagnosed/meet Dx criteria for AxPsA. 87%had already had CBP w/ previous episodes of uveitis. Men more likely to be clinically diagnosed ( 33%M vs13%F). https://t.co/2y0NxJOFRp
Meral K. El Ramahi, MD
Tweet
So excited to check out RheumNow’s ACR Mid-Meeting Recap live right now with Dr. Jack Cush (@rheumnow), Dr. Arthur Kavanaugh, Dr. Michale Pillinger, and Dr. Bella Mehta! #ACR20
Robert B Chao, MD
Tweet
Ultrasound to assess synovial-entheses junction correlated with clinical findings Abs#0311
Do you use MSK US in your clinic? @RheumNow #ACR20
Olga Petryna
Tweet
@RheumNow #acr20 abs0876 gender differences AS and nrSpA from 3 RCT IXE trials: F more likely to be older, have more nocturnal BP, peripheral pain&fatigue. M have higher CRP & +HLAB27. Ant uveitis > in M w/AS (23.8% vs. 17.9%) but > common in F w/ nr-axSpA (15.2% vs. 7.1%). https://t.co/HZa7AfWbBh
Dr. John Cush
Tweet
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow + its Faculty.
Janet Pope
Tweet
Are SpA response differences part of disease subsets or drug pharmacodynamics or both or neither? Data from COASTW & MEASURE2 @RheumNow #ACR2020 @CRASCRRheum https://t.co/GsFjZuZRvI
Rheum Cat
Tweet
Dr. Jonathan Kay with changes in ICD coding from ICD-9 to ICD-10.
And we just got an ICD code for nr-axSpA!
It's M46.80
https://t.co/JAlF4ERoHr
#ACR20 https://t.co/lmElQVtv35
Dr. Rachel Tate
Tweet
Dr. M. Dubreuil shares a beautiful slide describing the asynchrony between the goal and the reality in the classification of axSpA. Do you think it’s time to change our nomenclature and classification criteria? #ACR20 @RheumNow https://t.co/YJcvLKnyFy
Dr. Rachel Tate
Tweet
Dr. J. Kay reviews ICD11 classification codes for medical claims for diagnosing SpA which reviews ASAS criteria. This likely won’t be adopted in the US for several years. #ACR20 @RheumNow https://t.co/oDhs1EHSTP
Dr. Rachel Tate
Tweet
Do you know Walter Bauer, MD #ACR20? Well, I didn't either! Dr. M. Weinblatt taught me that Dr. Bauer was an important US rheumatologist who did NOT believe AS was a separate disease entity from RA! It wasn't until his death that the college recognized both separately! @RheumNow
Dr. John Cush
Tweet
Listen to part I of our #ACR20 Day 1 recap. Listen through the link below or find us on Apple podcasts.
https://t.co/W6EMQiF9Rf https://t.co/R1ieCFnIxz
